Jeff Link
Arqule (United States)(US)
Research Areas
PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments, Quinazolinone synthesis and applications, Cancer-related gene regulation
Most-Cited Works
- → Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors(2012)99 cited
- → Abstract LB-1: Discovery and optimization of orally bioavailable, selective and potent ATP-independent Akt inhibitors(2012)